ClinicalTrials.Veeva

Menu

The FLUYDO NC Post Market Clinical Follow-up Study

A

Alvimedica

Status

Completed

Conditions

Coronary Artery Disease
Vascular Diseases
Coronary Disease

Treatments

Device: FLUYDO NC percutaneous transluminal coronary angioplasty balloon catheter

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The aim of the present observational study is to collect clinical data on the medical device non-implantable medical device Fluydo NC: coronary angioplasty non-compliant balloon dilatation catheter in the daily use in a not selected population.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Turkish citizen,
  • ≥18 years of age,
  • Has indication for percutaneous transluminal coronary angioplasty (PTCA),
  • Has indication to treat obstructive lesions of a native coronary artery or aortocoronary bypass or needs post dilatation of coronary stent
  • Fluydo NC using in the primary lesion treated during the procedure by the decision physician,
  • Has signed and dated the informed consent.

Exclusion criteria

  • Has a previous diagnosis of coronary artery spasm in the absence of a significant stenosis.
  • Needs the device use in an unprotected left main coronary artery
  • Device use has not consistent with Instructions for Use.
  • Participating in another medical device or pharmaceutical clinical trial.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems